Stockreport

FDA Grants Orphan Drug Designation to Kadmon’s KD025 for the Treatment of cGVHD

Kadmon Holdings, Inc.  (KDMN) 
Last kadmon holdings, inc. earnings: 3/5 04:14 pm Check Earnings Report
US:NYSE Investor Relations: investors.kadmon.com
PDF NEW YORK--(BUSINESS WIRE)-- Kadmon Holdings, Inc. (NYSE: KDMN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug des [Read more]